Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)
This grant funds systematic testing of radionuclides in preclinical experiments.
About this program
The Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) grant is designed to support research that focuses on the evaluation and testing of radionuclides in preclinical settings. This initiative aims to enhance the understanding of radionuclide behavior and efficacy in various experimental models, ultimately contributing to advancements in medical applications. The grant is intended for researchers and institutions engaged in innovative preclinical research involving radionuclides. Eligible applicants include academic institutions, research organizations, and other entities involved in scientific research. The grant encourages collaboration among multidisciplinary teams to foster innovative approaches in the testing of radionuclides. By providing funding for this critical area of research, the STRIPE grant aims to facilitate breakthroughs that could lead to improved therapeutic strategies and diagnostic tools in the medical field.
Eligibility
Academic institutions, research organizations, and other entities involved in scientific research.